These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 6831436

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Preliminary communication--treatment of primary brain tumors recurrent after irradiation with aziridinylbenzoquinone (AZQ;NSC-182986).
    Eagan RT, Dinapoli RP, Hermann RC, Groover RV, Layton DD.
    Am J Clin Oncol; 1983 Oct; 6(5):577-8. PubMed ID: 6613923
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phase I study of aziridinylbenzoquinone (AZQ, NSC 182986) in children with cancer.
    Tan CT, Hancock CH, Mondora A, Hoffman NW.
    Cancer Res; 1984 Feb; 44(2):831-5. PubMed ID: 6692381
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Phase I trial and pharmacokinetics of aziridinylbenzoquinone (NSC 182986) in humans.
    Schilsky RL, Kelley JA, Ihde DC, Howser DM, Cordes RS, Young RC.
    Cancer Res; 1982 Apr; 42(4):1582-6. PubMed ID: 7060028
    [Abstract] [Full Text] [Related]

  • 9. Clinical and clinical pharmacologic studies of aziridinylbenzoquinone.
    Griffin JP, Newman RA, McCormack JJ, Krakoff IH.
    Cancer Treat Rep; 1982 Jun; 66(6):1321-5. PubMed ID: 7083235
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Decreased cytotoxicity of aziridinylbenzoquinone caused by polyamine depletion in 9L rat brain tumor cells in vitro.
    Alhonen-Hongisto L, Deen DF, Marton LJ.
    Cancer Res; 1984 Jan; 44(1):39-42. PubMed ID: 6418379
    [Abstract] [Full Text] [Related]

  • 13. Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory small cell carcinoma of the lung.
    Fuks JZ, Aisner J, Van Echo DA, Levitt M, Ihde DC, Carney D, Wiernik PH.
    Am J Clin Oncol; 1983 Apr; 6(2):171-3. PubMed ID: 6299094
    [Abstract] [Full Text] [Related]

  • 14. Phase I trial of 5-day continuous infusion aziridinylbenzoquinone (AZQ, diazaquone, NSC 182968).
    Sigman LM, Van Echo DA, Whitacre MY, Aisner J, Budman DA, Shulman P.
    Am J Clin Oncol; 1986 Feb; 9(1):79-82. PubMed ID: 3953494
    [Abstract] [Full Text] [Related]

  • 15. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
    Slagel DE, Feola J, Houchens DP, Ovejera AA.
    Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979
    [Abstract] [Full Text] [Related]

  • 16. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.
    Plum SM, Hanson AD, Volker KM, Vu HA, Sim BK, Fogler WE, Fortier AH.
    Clin Cancer Res; 2003 Oct 01; 9(12):4619-26. PubMed ID: 14555538
    [Abstract] [Full Text] [Related]

  • 17. Phase II trial of aziridinylbenzoquinone (AZQ) in head and neck cancer.
    Forastiere AA, Crain SM, Callahan K, Van Echo D, Mattox D, Thant M, Von Hoff DD, Wiernik PH.
    Cancer Treat Rep; 1982 Dec 01; 66(12):2097-8. PubMed ID: 6892491
    [No Abstract] [Full Text] [Related]

  • 18. Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory lymphoma.
    McLaughlin P, Cabanillas F, Bedikian AY, Bodey GP.
    Cancer Treat Rep; 1983 May 01; 67(5):507-8. PubMed ID: 6850666
    [No Abstract] [Full Text] [Related]

  • 19. Interaction of gamma-irradiation with two new antineoplastic agents, aziridinylbenzoquinone (AZQ) and 4'- (acridinylamino)methanesulfon-m-anisidide (AMSA), in murine tumors in vivo.
    Johnson RK, Wodinsky I, Swiniarski J, Meaney KF, Clement JJ.
    Int J Radiat Oncol Biol Phys; 1979 Sep 01; 5(9):1605-9. PubMed ID: 583418
    [No Abstract] [Full Text] [Related]

  • 20. Phase II and pharmacokinetic study of aziridinylbenzoquinone [2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone, diaziquone, NSC 182986] in high-grade gliomas.
    Curt GA, Kelley JA, Kufta CV, Smith BH, Kornblith PL, Young RC, Collins JM.
    Cancer Res; 1983 Dec 01; 43(12 Pt 1):6102-5. PubMed ID: 6640549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.